Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas

by palligoelme@gmail.com | Mar 9, 2026 | Clinical Trials

​ Conditions: Pituitary Adenoma Interventions: Drug: FET-PET/MRI Sponsors: Mayo Clinic Recruiting Conditions: Pituitary Adenoma Interventions: Drug: FET-PET/MRI Sponsors: Mayo Clinic Recruiting 

Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

by palligoelme@gmail.com | Mar 9, 2026 | Clinical Trials

​ Conditions: Coronary Heart Disease Sponsors: Josip Juraj Strossmayer University of Osijek Recruiting Conditions: Coronary Heart Disease Sponsors: Josip Juraj Strossmayer University of Osijek Recruiting 

FRONT Block for Quality of Recovery After Total Hip Arthroplasty

by palligoelme@gmail.com | Mar 9, 2026 | Clinical Trials

​ Conditions: Osteoarthritis of the Hip; Postoperative Pain; Quality of Recovery Interventions: Procedure: FRONT Block (Femoral Rami and Obturator Nerve Trunk Block); Procedure: Standard Multimodal Analgesia Sponsors: Konya Meram State Hospital Not yet...

Evaluating Universal Adhesives in Cervical Lesions

by palligoelme@gmail.com | Mar 9, 2026 | Clinical Trials

​ Conditions: Cervical Lesion; Dental Interventions: Device: G2 Bond Universal, GC Europe N.V., Leuven, Belgium; Device: Scotchbond Universal Plus, 3M ESPE, St. Paul, MN, USA; Device: Tokuyama Universal Bond II, Tokuyama Dental, Tokyo, Japan Sponsors: Hacettepe...

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

by palligoelme@gmail.com | Mar 6, 2026 | Clinical Trials

​ Conditions: Narcolepsy Type 1 Interventions: Drug: ALKS 2680 Dose 1; Drug: ALKS 2680 Dose 2; Drug: Placebo Sponsors: Alkermes, Inc. Not yet recruiting Conditions: Narcolepsy Type 1 Interventions: Drug: ALKS 2680 Dose 1; Drug: ALKS 2680 Dose 2; Drug: Placebo...